PT  - JOURNAL ARTICLE
AU  - Patel, Mayher J
AU  - DiStefano, Marina T
AU  - Oza, Andrea M
AU  - Hughes, Madeline Y
AU  - Wilcox, Emma H
AU  - Hemphill, Sarah E
AU  - Cushman, Brandon J
AU  - Grant, Andrew R
AU  - Siegert, Rebecca K
AU  - Shen, Jun
AU  - Chapin, Alex
AU  - Boczek, Nicole J
AU  - Schimmenti, Lisa A
AU  - Nara, Kiyomitsu
AU  - Kenna, Margaret
AU  - Azaiez, Hela
AU  - Booth, Kevin T
AU  - Griffith, Andrew
AU  - Avraham, Karen B
AU  - Kremer, Hannie
AU  - Rehm, Heidi L
AU  - Amr, Sami S
AU  - Abou Tayoun, Ahmad N
AU  - ,
TI  - Disease-specific ACMG/AMP guidelines improve sequence variant interpretation for hearing loss
AID  - 10.1101/2021.01.27.21250652
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.27.21250652
4099  - http://medrxiv.org/content/early/2021/01/31/2021.01.27.21250652.short
4100  - http://medrxiv.org/content/early/2021/01/31/2021.01.27.21250652.full
AB  - Purpose The ClinGen Variant Curation Expert Panels (VCEPS) provide disease-specific rules for accurate variant interpretation. Using hearing loss-specific American College of Medical Genetics/Association for Molecular Pathology (HL-specific ACMG/AMP) guidelines, the ClinGen Hearing Loss VCEP (HL VCEP) illustrates the utility of expert specifications in resolving conflicting variant interpretations.Methods A total of 157 variants across nine hearing loss genes were curated and submitted to ClinVar by the HL VCEP. The curation process consisted of collecting published and unpublished data for each variant by biocurators, followed by bi-monthly meetings of an expert curation subgroup that reviewed all evidence and applied the HL-specific ACMG/AMP guidelines to reach a final classification.Results Before expert curation, 75% (117/157) of variants had single or multiple VUS submissions (17/157) or had conflicting interpretations in ClinVar (100/157). After applying the HL-specific ACMG/AMP guidelines, 24% (4/17) of VUS variants and 69% (69/100) of discordant variants were resolved into Benign (B), Likely Benign (LB), Likely Pathogenic (LP), or Pathogenic (P). Overall, 70% (109/157) variants had unambiguous classifications (B, LB, LP, P). We quantify the contribution of the HL-specified ACMG/AMP codes to variant interpretation.Conclusion Expert specification and application of the HL-specific ACMG/AMP guidelines effectively resolved discordant interpretations in ClinVar. This study supports the utility of ClinGen VCEPs in helping the community move towards more consistent variant interpretations, which will improve the care of patients with genetic disorders.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch reported in this publication was supported by the National Human Genome Research Institute (NHGRI) under award number U41HG006834. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No Human subjects involved. No IRB required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll Data has been submitted to ClinVar. Please refer to Supplementary table 1 for a list of variants and their ClinVar IDs